Glycopyrronium (PT001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycopyrronium (PT001), covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma [Phase 2]